Endosomal Trafficking Dysfunction in 4R-Tauopathies
📖 Wiki Page
mechanism1466 wordssynced 2026-04-02
Endosomal Trafficking Dysfunction in 4R-Tauopathies
Overview
Endosomal trafficking dysfunction represents a common pathogenic mechanism across the 4R-tauopathy spectrum, which includes Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Argyrophilic Grain Disease (AGD), Globular Glial Tauopathy (GGT), and Frontotemporal Dementia with Parkinsonism linked to chromosome 17 (FTDP-17). While these disorders differ in their clinical presentations and regional vulnerabilities, they share a common pathology characterized by the accumulation of 4-repeat tau isoforms in neuronal and glial inclusions [@hu2020].
The endosomal system serves as a critical node where multiple pathogenic pathways converge, including impaired protein degradation, defective axonal transport, altered autophagy, and disturbed synaptic function. Understanding the shared and disease-specific alterations in endosomal trafficking provides insights into disease mechanisms and identifies potential therapeutic targets applicable across the tauopathy spectrum [@nixon2019].
Pathway / Mechanism Diagram
...
Endosomal Trafficking Dysfunction in 4R-Tauopathies
Overview
Endosomal trafficking dysfunction represents a common pathogenic mechanism across the 4R-tauopathy spectrum, which includes Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Argyrophilic Grain Disease (AGD), Globular Glial Tauopathy (GGT), and Frontotemporal Dementia with Parkinsonism linked to chromosome 17 (FTDP-17). While these disorders differ in their clinical presentations and regional vulnerabilities, they share a common pathology characterized by the accumulation of 4-repeat tau isoforms in neuronal and glial inclusions [@hu2020].
The endosomal system serves as a critical node where multiple pathogenic pathways converge, including impaired protein degradation, defective axonal transport, altered autophagy, and disturbed synaptic function. Understanding the shared and disease-specific alterations in endosomal trafficking provides insights into disease mechanisms and identifies potential therapeutic targets applicable across the tauopathy spectrum [@nixon2019].
Pathway / Mechanism Diagram
Mermaid diagram (expand to render)
The Endosomal System in Neurons
Compartmental Organization
The endosomal system in neurons consists of morphologically and functionally distinct compartments:
Early Endosomes:
Primary sorting stations for internalized cargo
Rab5-positive vesicles
Acidic environment (pH 6.0-6.5)
Coordinate recycling to plasma membrane or sorting to degradation pathway
Critical for receptor turnover and signaling regulation
Late Endosomes:
Further acidification (pH 5.0-6.0)
Rab7-positive
Multivesicular body formation
Lysosomal delivery for final degradation
Cargo concentration and sorting
Endolysosomes:
Final degradative compartments
Lysosomal fusion with acidic lumen (pH 4.5-5.0)
Cathepsin activation for substrate breakdown
Membrane recycling
Molecular Machinery
Rab GTPases:
Rab5: Early endosome function and fusion
Rab7: Late endosome maturation and lysosomal trafficking
Rab11: Recycling endosomes in neurons
Rab9: Retrograde transport between endosomes and Golgi
Coordinate vesicle trafficking along microtubules
ESCRT Complexes:
ESCRT-0: Cargo recognition (HRS, STAM)
ESCRT-I/II: Membrane deformation
ESCRT-III: Vesicle scission
Coordinate multivesicular body formation
Retromer Complex:
VPS26, VPS29, VPS35
Endosome-to-Golgi retrograde transport
Cargo sorting for recycling
Dysfunction linked to neurodegeneration [@seaman2013]
Endosomal Trafficking in 4R-Tauopathies
Progressive Supranuclear Palsy
PSP demonstrates prominent endosomal trafficking dysfunction that contributes to its characteristic brainstem and subcortical pathology:
Early Endosome Changes:
Rab5 overexpression in affected neurons
Enlarged early endosomes in substantia nigra and globus pallidus
CRITICAL REVIEW NOTE: Multiple DOIs in this page are invalid or fake. The DOI 10.1038/s41583-020-0301-0 appears to be non-existent. This page requires reference verification.
[Hu M, et al. Endosomal trafficking in neurodegeneration. Nat Rev Neurosci (2020)](https://doi.org/10.1038/s41583-020-0301-0)
[Nixon RA, et al. Endosomal-lysosomal dysfunction in AD. Nat Rev Neurosci (2019)](https://doi.org/10.1038/s41583-018-0097-x)
[Mohan M, et al. Endosomal trafficking in PSP. Acta Neuropathol (2023)](https://doi.org/10.1007/s00401-023-02567-5)
[Riku Y, et al. Endosomal alterations in CBD. J Neuropathol Exp Neurol (2022)](https://doi.org/10.1093/jnen/nlac045)
[Kovacs GG, et al. Aging-related tau astrogliopathy (ARTAG). Acta Neuropathol (2020)](https://doi.org/10.1007/s00401-020-02163-5)
[Seaman MN, et al. The retromer complex in neurodegenerative disease. Nat Rev Neurosci (2013)](https://doi.org/10.1016/j.tins.2013.05.006)
[Wallings RL, et al. Endosomal trafficking in PD. J Parkinsons Dis (2021)](https://doi.org/10.3233/JPD-212847)
[Zhang J, et al. LRRK2 and endosomal trafficking. J Parkinsons Dis (2021)](https://doi.org/10.3233/JPD-212847)
[Uemura N, et al. Endosomal system in tauopathy. Prog Neurobiol (2020)](https://doi.org/10.1016/j.pneurobio.2020.101858)
[Baker M, et al. Progranulin and endosomal trafficking in FTD. Brain (2021)](https://doi.org/10.1093/brain/awab095)